Epidemiological and molecular characteristics of hospital-acquired methicillin-resistant Staphylococcus aureus strains isolated in Hacettepe University Adult Hospital in 2004-2005;Hacettepe Üni̇versi̇tesi̇ Eri̧̇ki̇n Hastanesínde 2004-2005 yillarinda i̇zole edi̇len hastane kaynakli meti̇si̇li̇ne di̇rençli̇ Staphylococcus aureus suçlarinin epi̇demi̇yoloji̇k ve moleküler özelli̇kleri̇

Mikrobiyoloji Bulteni

Volumn 44, Issue 3, 2010, Pages 343-355

  Akočlu, Hadim ^a   Zarakolu, Pinar ^a   Altun, Belgin ^a   Ünal, Serhat ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Methidllin resistant staphylococcus aureus; Panton Valentine leukocidin; Staphylococcal chromosome cassette mec

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; MECA PROTEIN, STAPHYLOCOCCUS AUREUS; PANTON VALENTINE LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN;

ARTICLE; BACTEREMIA; CROSS INFECTION; GENETICS; HOSPITAL DEPARTMENT; HUMAN; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MULTIDRUG RESISTANCE; STAPHYLOCOCCUS INFECTION; SUPPURATION; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BACTERIAL TOXINS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXOTOXINS; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; SUPPURATION; SURGERY DEPARTMENT, HOSPITAL; TURKEY;

EID: 77956355000     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Benner EJ, Kayser FH. Growing clinical significance of methicillin-resistant Staphylococcus aureus. Lancet 1968; 2: 741-4.
2. Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 1999; 5: 9-17.
3. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290: 2976-84.
4. Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 1991; 29: 2240-4.
5. Katayama Y, lto T, Hiramatsu K. Genetic organization of the chromosome region surrounding mecA in clinical staphylococcal strains: role of 1S431-mediated mecl deletion in expression of resistance in mecA-carrying, low-level methicillin-resistant Staphylococcus haemolyticus. Antimicrob Agents Chemother 2001; 45: 1955-63.
6. Oliveira DC, Tomasz A, de Lencastre H. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microb Drug Resist 2001; 7: 349-61.
7. Eady EA, Cove JH. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus-an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 2003; 16: 103-24.
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. 1988. Am J Infect Control 1988; 16: 128-40.
9. Unal S, Hoskins J, Flokowitsch JE, Wu CY, Preston DA, Skatrud PL. Detection of methicillin-resistant staphylococci by using the polymerase chain reaction. J Clin Microbiol 1992; 30: 1685-91.
10. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46: 2155-61.
11. Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990; 28: 2059-63.
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth Informational Supplement M100-S1S, 2005. CLSI, Wayne, Pa.
13. Tiemersma EW, Bronzwaer SL, Lyytikäinen O, et al. European Antimicrobial Resistance Surveillance System Participants. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10: 1627-34.
14. Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteremia in the UK. J Antimicrob Chemother 2005; 56:455-62.
15. Khairulddln N, Bishop L, Lamagni TL, Sharland M, Duckworth G. Emergence of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia among children in England and Wales, 1990-2001. Arch Dis Child 2004; 89: 378-9.
16. lto T, Okuma K, Ma XX, Yuzawa H, Hiramatsu K. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Updat 2003; 6:41-52.
17. Borg MA, de Kraker M, Scicluna E, et al. ARMed Project Members and Collaborators. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries. J Antimicrob Chemother 2007; 60: 1310-5.
18. Tosun I, Udo EE, Noronha B, et al. Emergence of rifampicin resistance In methicillin-resistant Staphylococcus aureus isolated at a Turkish university hospital. Microb Drug Resist 2005; 11: 48-52.
19. Samra Z, Ofer O, Shmuely H. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycln and other antibiotics. Isr Med Assoc J 2005; 7: 148-50.
20. lto T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004;48:2637-51.
21. Oliveira DC, Tomasz A, de Lencastre H. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microb Drug Resist 2001; 7: 349-61.
22. Daum RS, lto T, Hiramatsu K, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 2002; 186: 1344-7.
23. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin- resistant Staphylococcus aureus infections In France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35: 819-24.
24. Wannet WJ, Spalburg E, Heck ME, et al. Emergence of virulent methicillin-resistant Staphylococcus aureus strains carrying Panton-Valentine leucocidin genes in The Netherlands. J Clin Microbiol 2005; 43: 3341-5.
25. Vandenesch F, Etienne J. How to prevent transmission of MRSA in the open community? Euro Surveill 2004; 9:5.
26. Ben Nejma M, Mastouri M, Frih S, Sakly N, Ben Salem Y, Nour M. Molecular characterization of methicillin-resistant Staphylococcus aureus isolated in Tunisia. Diagn Microbiol Infect Dis 2006; 55: 21-6.
27. Kilic A, Guclu AU, Senses Z, Bedir O, Aydogan H, Basustaoglu AC. Staphylococcal cassette chromosome mec (SCCmec) characterization and panton-valentlne leukocidin gene occurrence for methicillin-resistant Staphylococcus aureus in Turkey, from 2003 to 2006. Antonie Van Leeuwenhoek 2008; 94: 607-14.
28. Karahan ZC, Tekeli A, Adaletl R, Koyuncu E, Dolapci I, Akan OA. Investigation of Panton-Valentine leukocidin genes and SCCmec types in clinical Staphylococcus aureus isolates from Turkey. Microb Drug Resist 2008; 14:203-10.
29. Berglund C, Moiling P, Sjöberg L, Söderqulst B. Predominance of staphylococcal cassette chromosome mec (SCCmec) type IV among methicillin-resistant Staphylococcus aureus (MRSA) in a Swedish county and presence of unknown SCCmec types with Panton-Valentine leukocidin genes. Clin Microbiol Infect 2005; 11:447-56.
30. Boussaud V, Parrot A, Mayaud C, et al. Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus. Intensive Care Med 2003; 29: 1840-3.
31. Ramdani-Bouguessa N, Bes M, Meugnier H, et al. Detection of methicillin-resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine leukocidin genes in an Algiers hospital. Antimicrob Agents Chemother 2006; 50:1083-5.
32. Chini V, Petinakl E, Foka A, Paratiras S, Dimltracopoulos G, Spiliopoulou I. Spread of Staphylococcus aureus clinical isolates carrying Panton-Valentine leukocidin genes during a 3-year period in Greece. Clin Microbiol Infect 2006; 12:29-34.
33. Jarraud S, Mougel C, Thioulouse J, et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 2002; 70: 631-41.